Mohammad Sameer Khan
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoparticle-Based Drug Delivery 7
-
- Nanoplatforms for cancer theranostics 4
- Graphene and Nanomaterials Applications 2
- Co-authors
- Prashant Kesharwani (12 shared papers)Shadma Wahab (6 shared papers)B.H. Jaswanth Gowda (3 shared papers)Amirhossein Sahebkar (3 shared papers)Tanuja Singh (2 shared papers)Mallikarjuna Rao Pichika (1 shared paper)Nazim Nasir (1 shared paper)Waleed Hassan Almalki (2 shared papers)
- Journals
- International Journal of Pharmaceutics (3 papers)Journal of Drug Delivery Science and Technology (3 papers)Molecular Pharmaceutics (1 paper)Membranes (1 paper)Nanomedicine (1 paper)
- Partner nations
- IndiaSaudi ArabiaMalaysia
In The Last Decade
Mohammad Sameer Khan
16 papers receiving 434 citations
Peers
Comparison fields: 5 of 82
- Biomaterials 121
- Pharmaceutical Science 43
- Cancer Research 67
- Molecular Medicine 16
- Biomedical Engineering 121
Countries citing papers authored by Mohammad Sameer Khan
This map shows the geographic impact of Mohammad Sameer Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Sameer Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Sameer Khan more than expected).
Fields of papers citing papers by Mohammad Sameer Khan
This network shows the impact of papers produced by Mohammad Sameer Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Sameer Khan. The network helps show where Mohammad Sameer Khan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Sameer Khan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 104 | |
| 2 | 2023 | 61 | |
| 3 | 2024 | 44 | |
| 4 | 2023 | 37 | |
| 5 | 2024 | 36 | |
| 6 | 2023 | 33 | |
| 7 | 2024 | 24 | |
| 8 | 2022 | 22 | |
| 9 | 2024 | 22 | |
| 10 | 2024 | 15 | |
| 11 | 2024 | 12 | |
| 12 | 2025 | 9 | |
| 13 | 2025 | 8 | |
| 14 | 2025 | 8 | |
| 15 | 2025 | 6 | |
| 16 | 2017 | 1 | |
| 17 | 2025 | 0 |
About Mohammad Sameer Khan
Mohammad Sameer Khan is a scholar working on Biomaterials, Biomedical Engineering, Molecular Biology, Pharmaceutical Science and Materials Chemistry, having authored 17 papers that have together received 442 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Nanoplatforms for cancer theranostics (4 papers), Advanced biosensing and bioanalysis techniques (2 papers), Lipid Membrane Structure and Behavior (2 papers), Graphene and Nanomaterials Applications (2 papers), Nanoparticles: synthesis and applications (2 papers), Advancements in Transdermal Drug Delivery (2 papers) and Advanced Drug Delivery Systems (2 papers). The work is most often cited by research in Biomaterials (121 citations), Pharmaceutical Science (43 citations), Cancer Research (67 citations), Molecular Medicine (16 citations) and Biomedical Engineering (121 citations). Mohammad Sameer Khan has collaborated with scholars based in India, Saudi Arabia and Malaysia. Frequent co-authors include Prashant Kesharwani, Shadma Wahab, B.H. Jaswanth Gowda, Amirhossein Sahebkar, Tanuja Singh, Mallikarjuna Rao Pichika, Nazim Nasir, Waleed Hassan Almalki, Garima Gupta and Mahak Fatima. Their work appears in journals such as International Journal of Pharmaceutics, Journal of Drug Delivery Science and Technology, Molecular Pharmaceutics, Membranes and Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.